| 摘要 |
FIELD: medicine.SUBSTANCE: group of inventions refers to the long-term use of an parenteral formulation for producing a medicinal preparation for treating a HIV-infected individual with the above preparation applicable for subcutaneous or intramuscular injections and consists of brecanavir, or its salt in the form of an aqueous micro- or nanoparticle suspension containing Polysorbate 20, and is administered at regular intervals from 6 to 12 months, and to the above pharmaceutical composition.EFFECT: reducing the number of injections of the composition (preparation) in the absence of the additional agent ritonavir.7 cl, 4 dwg, 4 tbl |
